In a significant boost to India’s healthcare ecosystem, Gurugram-based Zoplar has secured $3.4 million in a Series A funding round.
The round was led by Blume Ventures, with participation from Beenext, Saison Capital, Atrium Angels, Finfirst, and LogX. This funding milestone raises Zoplar’s total investment to $5.1 million, following earlier support from Titan Capital, Stride Ventures, and Panthera Peak.
Zoplar, founded in 2022 by Amit Sah and Umesh Sharma, is transforming the medical equipment procurement process for small and medium-sized hospitals (MSMEs) across India. By addressing key challenges like cost efficiency, vendor management, financing, and after-sales services, the platform aims to simplify operations for these healthcare providers, empowering them to deliver high-quality care.
The latest infusion of funds will enable Zoplar to strengthen its supply chain through backward integration and develop a dedicated service engineering team. This strategic expansion is set to enhance the platform’s operational efficiency and service quality, ensuring a seamless experience for its growing network of hospital partners.
Speaking about the funding, co-founders Amit Sah and Umesh Sharma expressed their commitment to revolutionizing healthcare access: “This investment validates our mission to bridge gaps in India’s healthcare system. We are excited to scale our platform and continue empowering hospitals with affordable, reliable medical technologies that enable uninterrupted patient care.”
Zoplar has made remarkable strides since its inception, partnering with over 300 hospitals, including prominent nephrology chains such as DCDC. With a 40% repeat customer rate, the platform is quickly establishing itself as a trusted partner for healthcare providers across the country.
Sajith Pai, Venture Capitalist at Blume Ventures, remarked on Zoplar’s potential: “Zoplar is uniquely positioned to address critical pain points in the healthcare sector. Their innovative approach to medical equipment procurement and service delivery is perfectly aligned with our vision of investing in ventures that create meaningful societal impact.”
India’s healthcare sector is undergoing rapid growth, with MSME hospitals playing a pivotal role in bridging accessibility gaps in underserved regions. Despite their significance, these hospitals often struggle with operational inefficiencies and high costs associated with medical equipment procurement. Zoplar’s full-stack platform is designed to address these challenges, offering tailored solutions that improve affordability and service reliability.
With this fresh round of funding and its strategic roadmap, Zoplar is well-positioned to drive a transformation in India’s healthcare infrastructure. By enabling hospitals to streamline procurement and focus on patient care, the company is not just improving operational efficiency but also contributing to a more inclusive and sustainable healthcare system
